{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:02:14Z","timestamp":1740106934987,"version":"3.37.3"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00277-023-05215-4","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T13:02:53Z","timestamp":1682600573000},"page":"2291-2292","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Successful treatment with cyclosporine of pure red cell aplasia induced by obinutuzumab bendamustine therapy"],"prefix":"10.1007","volume":"102","author":[{"given":"Yutaka","family":"Shimazu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8867-7287","authenticated-orcid":false,"given":"Chisaki","family":"Mizumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhisa","family":"Chonabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Hanyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akifumi","family":"Takaori-Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"key":"5215_CR1","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1200\/JCO.1997.15.3.1110","volume":"15","author":"P Brice","year":"1997","unstructured":"Brice P, Bastion Y, Lepage E et al (1997) Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d\u2019Etude des Lymphomes Folliculaires. J Clin Oncol 15:1110\u20131117. https:\/\/doi.org\/10.1200\/JCO.1997.15.3.1110","journal-title":"J Clin Oncol"},{"key":"5215_CR2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S0140-6736(03)14110-4","volume":"362","author":"KM Ardeshna","year":"2003","unstructured":"Ardeshna KM, Smith P, Norton A et al (2003) Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial. Lancet 362:516\u2013522. https:\/\/doi.org\/10.1016\/S0140-6736(03)14110-4","journal-title":"Lancet"},{"key":"5215_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.leukres.2005.05.017","volume":"30","author":"K Narra","year":"2006","unstructured":"Narra K, Borghaei H, Al-Saleem T et al (2006) Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature. Leuk Res 30:109\u2013114. https:\/\/doi.org\/10.1016\/j.leukres.2005.05.017","journal-title":"Leuk Res"},{"key":"5215_CR4","first-page":"80","volume":"25","author":"LF Diehl","year":"1998","unstructured":"Diehl LF, Ketchum LH (1998) Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia. Semin Oncol 25:80\u201397","journal-title":"Semin Oncol"},{"key":"5215_CR5","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1182\/blood.v96.3.1184.015k54_1184_1186","volume":"96","author":"VR Sharma","year":"2000","unstructured":"Sharma VR, Fleming DR, Slone SP (2000) Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab. Blood 96:1184\u20131186. https:\/\/doi.org\/10.1182\/blood.v96.3.1184.015k54_1184_1186","journal-title":"Blood"},{"key":"5215_CR6","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1182\/blood.v87.7.3000.bloodjournal8773000","volume":"87","author":"MQ Lacy","year":"1996","unstructured":"Lacy MQ, Kurtin PJ, Tefferi A (1996) Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities. Blood 87:3000\u20133006. https:\/\/doi.org\/10.1182\/blood.v87.7.3000.bloodjournal8773000","journal-title":"Blood"},{"key":"5215_CR7","first-page":"275","volume":"28","author":"EN Dessypris","year":"1991","unstructured":"Dessypris EN (1991) The biology of pure red cell aplasia. Semin Hematol 28:275\u2013284","journal-title":"Semin Hematol"},{"key":"5215_CR8","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3109\/10428190109064614","volume":"42","author":"H Katayama","year":"2001","unstructured":"Katayama H, Takeuchi M, Yoshino T et al (2001) Epstein-Barr virus associated diffuse large B-cell lymphoma complicated by autoimmune hemolytic anemia and pure red cell aplasia. Leuk Lymphoma 42:539\u2013542. https:\/\/doi.org\/10.3109\/10428190109064614","journal-title":"Leuk Lymphoma"},{"key":"5215_CR9","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/j.1875-9114.1996.tb03025.x","volume":"16","author":"DF Thompson","year":"1996","unstructured":"Thompson DF, Gales MA (1996) Drug-induced pure red cell aplasia. Pharmacotherapy 16:1002\u20131008","journal-title":"Pharmacotherapy"},{"key":"5215_CR10","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/(SICI)1096-8652(199704)54:4<324::AID-AJH12>3.0.CO;2-B","volume":"54","author":"M Masuda","year":"1997","unstructured":"Masuda M, Arai Y, Okamura T, Mizoguchi H (1997) Pure red cell aplasia with thymoma: evidence of T-cell clonal disorder. Am J Hematol 54:324\u2013328. https:\/\/doi.org\/10.1002\/(SICI)1096-8652(199704)54:4%3c324::AID-AJH12%3e3.0.CO;2-B","journal-title":"Am J Hematol"},{"key":"5215_CR11","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/ajh.20374","volume":"79","author":"M Masuda","year":"2005","unstructured":"Masuda M, Teramura M, Matsuda A et al (2005) Clonal T cells of pure red-cell aplasia. Am J Hematol 79:332\u2013333. https:\/\/doi.org\/10.1002\/ajh.20374","journal-title":"Am J Hematol"},{"key":"5215_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/or.2022.8325","volume":"47","author":"H Lalic","year":"2022","unstructured":"Lalic H, Aurer I, Batinic D et al (2022) Bendamustine: a review of pharmacology, clinical use and immunological effects (Review). Oncol Rep 47:1\u201316. https:\/\/doi.org\/10.3892\/or.2022.8325","journal-title":"Oncol Rep"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05215-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05215-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05215-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T16:11:39Z","timestamp":1702311099000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05215-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,27]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["5215"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05215-4","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2023,4,27]]},"assertion":[{"value":"13 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in this study involving the patient were in accordance with the ethical standards of our institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the patient in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}